Product News
Sino Biological Announces Services Partnership With Rapid Novor
Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services.
Product News
UC Enuity Is the Next Generation Ultramicrotome That Saves Users Valuable Time
Leica Microsystems, has launched UC Enuity, the next generation ultramicrotome for electron microscopy sample preparation.
Product News
Viroclinics-DDL Changes Name to Cerba Research
Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), proudly announces changing its name to Cerba Research as of the 1st of April 2024.
Product News
ProBioGen Partners With MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease
ProBioGen, is pleased to announce the execution of services and license agreements with MAPP BIOPHARMACEUTICAL, INC. to develop a cell line for an afucosylated antibody targeting Marburg virus (MARV) infection.
Product News
Enpicom Partners With Erasmus University Medical Center in Groundbreaking Effort To Discover Nanobodies Against Cancer
Erasmus University Medical Center uses ENPICOM’s IGX Platform and services to advance their research on identifying cancer nanobodies.
Product News
Beckman Coulter Life Sciences Achieves Industry-First With Commercial Release of Anti-TRBC2 Conjugated Antibody for Flow Cytometry
New advancement builds on 25-year commitment to T-Cell research.
Product News
Thermo Fisher Scientific Introduces New Sample Preparation Solutions To Simplify and Automate Respiratory Diagnostic Testing
New Thermo Scientific KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit improve preanalytical workflows for clinical laboratories.
Product News
Oxford Nanopore and Day Zero Diagnostics Partner To Develop a New Class of Bloodstream Infection Diagnostics
Oxford Nanopore, and Day Zero Diagnostics (DZD), announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.
Product News
Tune Therapeutics Reveals Epigenetic Editing Program Targeting Hepatitis B Virus
The mechanism targets both integrated virus and cccDNA; expected to begin clinical testing by end of 2024. Preclinical program data to be presented at the 2023 Hep DART Conference .
Product News
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria
Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.
Advertisement
